About the journal
Clinical Lymphoma Myeloma & Leukemia is a journal published by Elsevier BV in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,670 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 2152-2650 · 2152-2669
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 3,670 USD
- Declared peer-review model
- peer_review
- Official website
- http://www.clinical-lymphoma-myeloma-leukemia.com/
Index listings
- MEDLINE · 2010-01-01
- Indexing
- MEDLINE
- APC
- 3,670 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 41 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
16622
Last recorded publication year
2026
h-index
66
i10-index
1356
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 8%
- ORCID iDs in current deposits
- 6%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Clinical lymphoma, myeloma and leukemia
- Source type
- journal
- NLM unique ID (PubMed)
- 101525386
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
Show all subjects (50)
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CAR-T cell therapy research
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CAR-T cell therapy research
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Hematopoietic Stem Cell Transplantation
- Cutaneous lymphoproliferative disorders research
- Hematopoietic Stem Cell Transplantation
- CNS Lymphoma Diagnosis and Treatment
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Monoclonal and Polyclonal Antibodies Research
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Neutropenia and Cancer Infections
- Monoclonal and Polyclonal Antibodies Research
- CNS Lymphoma Diagnosis and Treatment
- Neutropenia and Cancer Infections
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cutaneous lymphoproliferative disorders research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Immunodeficiency and Autoimmune Disorders
- Viral-associated cancers and disorders
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Immunodeficiency and Autoimmune Disorders
- Lung Cancer Treatments and Mutations
- Viral-associated cancers and disorders
- Lung Cancer Treatments and Mutations
- Hemoglobinopathies and Related Disorders
- Retinoids in leukemia and cellular processes
- Hemoglobinopathies and Related Disorders
- Hematological disorders and diagnostics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ